Group 1 - The core viewpoint of the article is that Wantai Biological Pharmacy Enterprise Co., Ltd. has been exporting its products to EU countries in recent years, primarily through direct exports from domestic entities to EU clients [1] Group 2 - The company has engaged in international trade, indicating a strategic expansion into European markets [1] - The focus on direct exports suggests a proactive approach to market penetration and customer engagement in the EU [1]

Group 1 - The core viewpoint of the article is that Wantai Biological Pharmacy Enterprise Co., Ltd. has been exporting its products to EU countries in recent years, primarily through direct sales to EU customers from domestic entities [1] Group 2 - The company has engaged in direct exports to EU clients, indicating a strategic move to expand its market presence internationally [1] - The interaction with investors highlights the company's commitment to transparency regarding its export activities [1]

Group 1 - The company, Wantai Biological Pharmacy, confirmed that all its products are developed and produced in strict compliance with national regulations [2] - The products have passed rigorous reviews and registration checks by the National Medical Products Administration [2] - After obtaining the batch release certificate, the products are available for market sales [2]